Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer

por Brodsky, Alexander S., Xiong, Jinjun, Yang, Dongfang, Schorl, Christoph, Fenton, Mary Anne, Graves, Theresa A., Sikov, William M., Resnick, Murray B., Wang, Yihong
Publicado 2016

Stromal ColXα1 expression correlates with tumor-infiltrating lymphocytes and predicts adjuvant therapy outcome in ER-positive/HER2-positive breast cancer

por Zhao, Chaohui Lisa, Singh, Kamaljeet, Brodsky, Alexander S., Lu, Shaolei, Graves, Theresa A., Fenton, Mary Anne, Yang, Dongfang, Sturtevant, Ashlee, Resnick, Murray B., Wang, Yihong
Publicado 2019